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Recently we have described the distribution of bovine spongiform encephalopathy (BSE) infectivity and/or PrPSc in
Peyer’s patches (PP) of the small intestine of orally BSE infected cattle. In this follow-up study additional jejunal and
ileal PP’s and ileocaecal-junction tissue samples from 1, 4, and 24 months post infection (mpi) were examined by
mouse (Tgbov XV) bioassay. Infectivity was demonstrated in ileal PP’s 4 mpi and the distribution/extent of infectivity
at 24 mpi was comparable to those seen at earlier time points, revealing no indication for a decline/clearance.
These data are relevant for the definition of Specified Risk Materials in the context of the TSE legislation worldwide.Introduction, methods, and results
Bovine spongiform encephalopathy (BSE) belongs to the
group of transmissible spongiform encephalopathies (TSE)
and is associated with the accumulation of a pathological
isoform of a host-encoded glycoprotein, prion protein
(PrPSc). PrPSc can be distinguished from its cellular pro-
genitor by its partial proteinase K resistance and hydro-
phobicity which lead to the formation of fibrils in-vivo
and/or in-vitro. Classical BSE was transmitted by the oral
uptake of infectious feedingstuff [1] to ruminants such as
bovines [2] and goats [3], felidae [4] and humans [5]. In
the European Union (EU) and in a number of other coun-
tries the BSE exposure risk for humans is minimized by
the removal of specified risk materials (SRM) from slaugh-
tered cattle that may contain BSE infectivity in incubating
animals. Among other tissues this regards, at least in the
EU, the intestine. Several authors have described BSE in-
fectivity and/or PrPSc accumulations in the ileum [6-11],
but data on jejunum and colon are patchy [10-12]. In a
study we published two years ago [10] we have detected
BSE infectivity in jejunum, ileum and ileocaecal-junction
of BSE incubating cattle from 8 to 20 months post* Correspondence: martin.groschup@fli.bund.de
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stated.infection (mpi) with peak levels at 12 mpi. However, im-
munohistochemistry (IHC) results suggested also the pos-
sibility of prion amplification in animals 4 mpi and earlier
as well as a time dependent variation in the detectable
amounts of PrPSc up to an age of 24 mpi. This follow up
study presented here therefore intended to clarify when
BSE infectivity can be found in the small intestine at the
earliest time point post infection and also focused on older
cattle to prove whether the undulant pattern seen in IHC
is reflected by varying infectivity levels. These data are im-
portant for a risk-based definition of the gut associated
SRM which is needed in the currently ongoing discussion
in the EU whether restrictions for the intestinal SRM tis-
sues can be alleviated.
All infection experiments in cattle and mice described in
this manuscript were approved by the competent authority
of the Federal State of Mecklenburg-Western Pomerania,
Germany, on the basis of national and European legislation,
namely the EU council directive 86/609/EEC for the pro-
tection of animals used for experiments.
As described before [10,13], 56 Simmental calves aged
four to six months were orally inoculated with 100 g of
a brain stem homogenate pooled from clinically infected
BSE cattle. The infectivity load in the homogenate was
106.1 ID50/g tissues as determined by end point titration
in TgbovXV mice. Eighteen calves inoculated orally with. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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five animals were randomly selected, culled and necrop-
sied after 1, 4, 8, 12 etc. mpi and a wide range of tissue
samples was taken under TSE sterile conditions. Speci-
mens from eight infected bovines killed after 1, 4, and 24
mpi and from one control animal (4 mpi) were examined
here. Anamnestic data are listed in Table 1. Peyer’s patches
from four localizations [10], including two samples from
the jejunum and one from each the ileum and ileocaecal-
junction were tested for infectivity by mouse bioassay
using bovine PrP overexpressing transgenic mice (Tgbov
XV) [7]. Fifteen mice per sample were inoculated intrace-
rebrally (30 μL) with 10% tissue homogenates diluted in
sterile 0.9% sodium chloride solution. During the incuba-
tion time all mice were assessed for the onset of clinical
symptoms at least two times per week. Mice showing clin-
ical signs were sacrificed and their brains tested for the ac-
cumulation of PrPSc by a PTA immunoblotting method as
described before [10].
Results of the PrPSc analysis and of the bioassay are
shown in Table 1. Six out of the eight BSE infected cows
carried infectivity at least in one of the gut localizations.
The control cow as well as the animals killed one mpi
showed no signs of infectivity. The earliest time point of
detection was in both cows culled at four mpi. All animals
which gave positive results in the mouse bioassay revealed
signs of infectivity at least in the ileal sample. Three out of
the four cows sacrificed at 24 mpi had accumulated infect-
ivity in jejunal PP’s as well as in the ileocaecal-junction.
Animal IT47 (24 mpi) even had accumulated infectivity in
all examined intestine samples.
Infectivity levels at the different localizations of the small
intestine were unequal, with the highest levels in the ileal
PP’s followed by the ileocaecal-junction and jejunal sam-







KT32 4 Control – −−/−−
IT04 1 Preclinical – −−/−−
IT44 1 Preclinical – −−/−−
IT19 4 Preclinical – +/−−
IT45 4 Preclinical – +/−−
IT26 24 Late preclinical + ++/−− 8
IT24 24 Preclinical – ++/−−
IT47 24 Preclinical – +++/−−
IT58 24 Preclinical – −−/+
*All jejunal samples were negative in IHC, mpi: months post infection; IHC: Immuno
Mouse bioassay results relying on PTA-Western blot of mouse brains: the first numb
brackets indicates the mean incubation period in days post infection and the standbetween 66% and 100% of the mice affected) and shortest
incubation periods (mean value 327 days, ± 56) were ob-
served in the bioassay. Only one animal (IT58, 24 mpi)
displayed sparse amounts of infectivity in this sample.
More variable were the results obtained for ileocaecal-
junction samples. At this location cow IT24 (24 mpi) car-
ried infectivity levels comparable to those in the ileal PP’s,
while two other cows (IT26, IT47, both 24 mpi) showed
only low infectivity levels at this site, as indicated by low
bioassay transmission rates (two or three mice affected
having prolonged incubation periods from 354 up to 725
dpi. Bioassay results for jejunal PP’s were quite diverse
with singular diseased mice per group and long incubation
periods (440 up to 533 dpi) for most animals 24 mpi, and
none in the animals that were sacrificed earlier. However,
there was also one cow which was in the late preclinical
state, IT 26 (24 mpi), where the jejunal PP’s yielded a bio-
assay transmission rate of more than 50% with an average
incubation time of 440 days.
Discussion
In this follow-up study we have mapped the exact tem-
poral and spatial emergence and distribution of infectivity
in the PP’s of the small intestine in orally BSE infected cat-
tle. According to IHC results described previously [10,11],
infectivity was first seen four months after the oral chal-
lenge. However in IHC only traces of PrPSc were seen in
single follicles of the ileal PP’s at four mpi [10]. This is not
reflected by the results presented here, showing already
moderate to high amounts of infectivity comparable to
levels at later stages of disease [10]. As the detection of in-
fectivity mostly precedes the detection of PrPSc, these re-
sults support the theory that the latent period post
exposure during which no detectable infection is present
might be around two or three months.om [10]) and mouse bioassay results of all
Mouse bioassay (Tgbov XV)
Jejunum A Jejunum B Ileum Ileocaec-junct
0/11 0/15 0/11 0/15
0/10 0/13 0/13 0/11
0/13 0/15 0/12 0/13
0/12 0/13 9/15 (380 ± 65) 0/14
0/15 0/14 11/13 (366 ± 46) 0/12
/14 (440 ± 96) 0/13 14/14 (317 ± 36) 2/11 (414, 526)
1/13 (533) 0/14 15/15 (328 ± 52) 12/14 (325 ± 45)
1/15 (448) 2/12 (434, 707) 13/13 (267 ± 20) 3/12 (354,536,725)
0/12 0/15 2/12 (442, 445) 0/15
histochemistry; – negative result, +/++ mild/moderate accumulation of PrPSc,
ers indicate the number of positive mice/inoculated mice, the number in
ard deviation.
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bution of PrPSc at 24 mpi, since the extent of this accu-
mulation varied at earlier time points with peaks at 8
and in particular 12 mpi and lows at 16 mpi respectively
[10]. However, these earlier studies did also suggest a
higher amount in animals at 24 mpi suggesting an undu-
lant pattern of about 12 months. This finding is now
supported by the bioassay results, as three out of the
four cattle from the 24 mpi group showed levels and dis-
tribution of infectivity comparable to the peaks seen at
12 mpi. However it has to be bear in mind that only four
animals per time point were investigated here and in
earlier studies and that the variations between individ-
uals are very high [10,14]. This is reflected in the present
study by variable detection rates in different animals of
the 24 mpi group and might explain the differences seen
in infectivity levels reported for ileal samples by several
authors before [6,9-11,15].
In summary, data presented here clearly showed that
infectivity is not detectable in the small intestine of ani-
mals up to four months post experimental oral exposure
with an extremely high dose. Moreover, the low amounts
of infectivity detectable after the peak at 12 mpi as dem-
onstrated previously, does not imply an irreversible
clearance of the infectious agent from the gut over time,
but is rather a time-dependent individual fluctuation, as
a higher infectivity load is seen again at 24 mpi. Hence,
the data presented here are important for a risk- based
SRM definition.
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